Charles Fracchia

Bioeconomy executive focusing on manufacturing assurance, strategic security and resilience.
CEO of Black Mesa & Chairman of BIO-ISAC


Mr. Fracchia is the CEO of Black Mesa, a Boston-based company in stealth mode building systems and tools to provide unprecedented manufacturing assurance

Charles is also the Co-Founder of BIO-ISAC, an international organization that addresses threats unique to the bioeconomy and enables coordination among stakeholders to facilitate a robust and secure industry.

He was the founder and CEO of BioBright (acquired by Dotmatics), the company that created the first -and still only- end-to-end encrypted data collection and analysis for life science and scientific environments.

Charles received his graduate education between the the Church Lab at Harvard Medical School and the MIT Media Lab. He obtained his bachelor’s degree from Imperial College London. Charles gained critical experience from his work at IBM Research and Ginkgo Bioworks where he was respectively the first synthetic biologist and first full-time person outside of the founding team.

He has received a number of awards including MIT Technology Review’s 35 under 35, IBM PhD fellowships and the Extraordinary Minds fellowship. He holds patents digital tools for biological systems and nanoengineering using DNA origami, and is the author of articles and a book chapter in the field of digital biosecurity.

In 2021, the US Defense Advanced Research Projects Agency (DARPA) named Charles Fracchia to its Information Science and Technology (ISAT) Study Group. The group brings 30 of the brightest scientists and engineers together to identify new areas of development in computer and communication technologies, and to recommend future research directions. The ISAT Study Group was established by DARPA in 1987 to support its technology offices and provide continuing and independent assessment of the state of advanced information science and technology as it relates to the U.S. Department of Defense.

Mr Fracchia is passionate about solving problems at the intersection of biological industry, technology and governments in ways that improve the security and resilience of systems world-wide.